|
Volumn 361, Issue 14, 2009, Pages 1410-1411
|
Renal and retinal effects of enalapril and losartan in type 1 diabetes [6]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
LOSARTAN;
ANGIOTENSIN RECEPTOR ANTAGONIST;
DIABETIC NEPHROPATHY;
DIABETIC RETINOPATHY;
HUMAN;
HYPERTENSION;
INSULIN DEPENDENT DIABETES MELLITUS;
LETTER;
MICROALBUMINURIA;
PRIORITY JOURNAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
TREATMENT OUTCOME;
DISEASE COURSE;
DRUG EFFECT;
GENETIC PREDISPOSITION;
GENETICS;
NOTE;
PATIENT SELECTION;
ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
DIABETES MELLITUS, TYPE 1;
DIABETIC NEPHROPATHIES;
DIABETIC RETINOPATHY;
DISEASE PROGRESSION;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
HYPERTENSION;
PATIENT SELECTION;
RENIN-ANGIOTENSIN SYSTEM;
|
EID: 70349627425
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc091561 Document Type: Letter |
Times cited : (9)
|
References (4)
|